In the BioHarmony Drug Report Database

"Preview" Icon

Gemifloxacin

Factive (gemifloxacin) is a small molecule pharmaceutical. Gemifloxacin was first approved as Factive on 2003-04-04. It is used to treat bacterial infections, bronchitis, community-acquired infections, gram-negative bacterial infections, and pneumococcal pneumonia amongst others in the USA.

 

Trade Name

 

Factive
 

Common Name

 

gemifloxacin
 

ChEMBL ID

 

CHEMBL430
 

Indication

 

bacterial infections, bronchitis, community-acquired infections, gram-negative bacterial infections, pneumococcal pneumonia, protozoan infections, urinary tract infections
 

Drug Class

 

Antibacterials (quinolone derivatives)

Image (chem structure or protein)

Gemifloxacin structure rendering